INNOVENT BIO (01801) turns around, FY25 profit RMB813.56M X
26/03/2026 17:36
(Infocast News)      Results of Innovent Biologics, Inc. (01801) for the fiscal year ended 31 December 2025:

Net profit: RMB813.565M (RMB94.631M net loss for the same period last year) 
Basic EPS: RMB0.48
Dividend per share proposed: (Nil)

(WL)

(C) Copyright by Infocast Ltd. All Rights Reserved.

Infocast Limited and its information providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.